Status:
ACTIVE_NOT_RECRUITING
Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone
Lead Sponsor:
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Conditions:
Giardia Lamblia Infection
Eligibility:
MALE
18-27 years
Phase:
PHASE2
PHASE3
Brief Summary
20-hydroxyecdysone is an ecdysteroid hormone found in invertebrates and plants. 20-hydroxyecdysone exhibits a broad range of biological properties in various in vitro and in vivo models, including ana...
Detailed Description
The randomized, double-blinded, placebo-controlled clinical study will be conducted by the Uzbek State University of Physical Education and Sport, Institute of the Chemistry of Plant Substances named ...
Eligibility Criteria
Inclusion
- \- a presence of giardia lamblia in stool samples of partisipants
Exclusion
- chronic and acute infectious diseases,
- endocrine diseases, congenital diseases,
- allergic dermatitis,
- bronchial asthma,
- allergic rhinitis and/or conjunctivitis,
- other skin disorders,
- history of using vitamin D supplements within three months ago, or use of any medication influencing endocrine parameters.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04827537
Start Date
January 1 2021
End Date
December 31 2027
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research institute of epidemiology, microbiology and infectious diseases
Tashkent, Uchtepa, Uzbekistan, 100133